MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
Clinical trial NCT00722371 · COMPLETED
Trial details
- NCT number
- NCT00722371
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-05
- Primary completion
- 2010-10-26
- Enrollment
- 1615
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.